What are the considerations for undergoing a bursectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Considerations for Bursectomy in Gastric Cancer Treatment

Bursectomy should be avoided in T1/T2 gastric tumors due to risk of pancreatic injury and lack of survival benefit, but may be considered for tumors penetrating the serosa of the posterior gastric wall (T3/T4a) to remove potential microscopic tumor deposits in the lesser sac. 1

Definition and Purpose

  • Bursectomy is the removal of the inner peritoneal surface of the bursa omentalis (omental bursa), performed with the aim of removing microscopic tumor deposits in the lesser sac 1
  • It has historically been considered part of radical surgery for gastric carcinoma in Japan, particularly for serosa-positive gastric cancer 2

Evidence-Based Recommendations

Tumor Stage Considerations

  • Early-stage tumors (T1/T2): Bursectomy should be avoided to prevent injury to the pancreas and adjacent blood vessels 1
  • Advanced tumors (T3/T4a): May be considered for tumors penetrating the serosa of the posterior gastric wall 1
  • A small-scale randomized controlled trial suggested a survival benefit for bursectomy in T3/T4a tumors, but more definitive evidence was needed 1

Recent Evidence on Efficacy

  • The JCOG1001 large-scale multi-institutional randomized trial was conducted to address the efficacy of bursectomy 1, 3
  • Final results after 5-year follow-up showed no survival benefit:
    • 5-year overall survival rates: 74.9% in bursectomy group vs. 76.5% in omentectomy-alone group 3
    • Bursectomy did not decrease peritoneal recurrence (12.1% vs. 12.3%) 3
    • The adjusted hazard ratio for death in the bursectomy group was 1.03 (95% CI 0.83 to 1.27) 3

Surgical Complications

  • Bursectomy is associated with a significantly higher incidence of Clavien-Dindo grade III-IV intra-abdominal abscess compared to omentectomy alone (5.5% vs. 2.5%) 3
  • Risk of injury to the pancreas and adjacent blood vessels, especially in T1/T2 tumors 1

Technical Considerations

  • Can be performed during both open and laparoscopic gastrectomy, though laparoscopic bursectomy is technically more challenging 2
  • Requires expertise in advanced gastric cancer surgery 2

Rationale for Limited Use

  • Cancer cells disseminated into the bursa rarely remain restricted to this cavity without migrating into the free abdominal cavity 4
  • In a study of peritoneal washes, only 2 out of 136 patients had cancer cells exclusively in the omental bursa 4
  • The Italian Research Group for Gastric Cancer (GIRCG) acknowledges that bursectomy may be performed when the posterior gastric wall serosa is infiltrated, but notes the limited evidence 1

Current Recommendation

  • Based on the JCOG1001 trial results, bursectomy is not recommended as a standard procedure for cT3-T4a gastric cancer in D2 gastrectomy 3
  • The procedure should be reserved for selected cases where there is high suspicion of microscopic tumor deposits in the lesser sac 1
  • Multivariable analysis from JCOG1001 identified several independent predictors of poor overall survival (age >65 years, tumor in lower third/posterior wall, macroscopic type 3/5, total gastrectomy, and cT4a), but omentectomy alone was not associated with worse outcomes 3

Special Considerations

  • For patients with tumors penetrating the serosa of the posterior gastric wall, the decision to perform bursectomy should be made by an experienced surgeon based on individual tumor characteristics 1
  • The potential marginal benefit in specific cases must be weighed against the increased risk of complications 3, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.